Target intelligence / Profile preview

Undecaprenyl phosphate (Und-P) (Und-P)

Target
Und-P
Molecular classification
Lipid carrier, Isoprenoid, Other
01

Overview

Undecaprenyl phosphate, also known as bactoprenol phosphate, is a critical 55-carbon isoprenoid lipid carrier essential for the biosynthesis of the bacterial cell wall (PubChem CID 6433164). It functions as a membrane-bound shuttle that transports hydrophilic precursors, such as the N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) building blocks of peptidoglycan, across the cytoplasmic membrane (Manat et al., 2014, Microbial Drug Resistance). Once these precursors are delivered to the external side of the membrane for polymerization, the resulting undecaprenyl pyrophosphate must be dephosphorylated back to its monophosphate form to be reused in subsequent transport cycles (PubMed ID: 25130115). This recycling process is a major vulnerability in bacterial metabolism and is the primary target of the antibiotic bacitracin, which binds to the pyrophosphate intermediate and prevents its conversion back to the active monophosphate form (StatPearls, Bacitracin). Because this lipid carrier is indispensable for bacterial survival and lacks a direct human counterpart, it represents a highly effective target for antimicrobial therapy, particularly against Gram-positive pathogens (Nature Reviews Microbiology, 2005). Beyond peptidoglycan, it is also involved in the synthesis of other cell surface polysaccharides like teichoic acids and O-antigens (UniProt). Therapeutic challenges include the high nephrotoxicity of systemic agents targeting this pathway, which often limits their clinical use to topical applications (NIH LiverTox). Research continues into novel compounds that can sequester the lipid carrier directly to overcome resistance mechanisms (Nature Communications, 2017).

Other names
Bactoprenol phosphateC55-isoprenyl phosphateUndecaprenyl monophosphateBactoprenol monophosphateC55-P
02

Mechanism of action

Inhibition of undecaprenyl pyrophosphate dephosphorylation, which prevents the regeneration of the active undecaprenyl phosphate carrier required for cell wall precursor transport (StatPearls, Bacitracin).

03

Biological functions

Cell wall biosynthesisLipid transportOther
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityLimited systemic bioavailabilityTopical-only administration for certain drugs (NIH LiverTox)
06

Interacting drugs

Bacitracin

3 more in the full profile.

07

Biomarkers

Bacterial loadPeptidoglycan precursor accumulation

Beyond the preview

Go deeper on Undecaprenyl phosphate (Und-P) (Und-P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Undecaprenyl phosphate (Und-P) (Und-P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call